BPA #36C25926A0033

Blanket Purchase Agreement for Molecular Genetic Testing by Natera Inc.

This award represents a blanket purchase agreement, a type of indefinite delivery vehicle designed to facilitate ongoing acquisitions without requiring repetitive solicitations. The contract recipient, Natera Inc, is a leading biotechnology company specializing in molecular genetic testing and diagnostics. Under this contract, Natera will provide advanced molecular genetic testing services specifically aimed at detecting transplant rejection, a critical process in ensuring the success and longevity of organ transplants. The significance of this contract lies in its potential to improve transplant patient outcomes through precise and timely rejection detection, thereby supporting the healthcare mission of the contracting agency. The scope encompasses ongoing genetic testing services, employing sophisticated molecular techniques to assess transplant viability. This contract was likely awarded through a competitive process to ensure the best value and expertise, although specific details on bidding are not provided. The agreement spans multiple years, covering a long-term period into the future, enabling sustained service delivery. No subcontractor or previous contract information is available at this time, and no specific contract vehicle beyond the blanket purchase agreement was specified.

Description

MOLECULAR GENETIC TESTING FOR TRANSPLANT REJECTION DETECTION

View original record